Clinical evidence and research
The Low Carb Program is built upon a robust evidence-base and supported by peer-reviewed clinical health and engagement outcomes
Peer-reviewed one-year health outcomes
We’re conducting a three year study following 1,000 people with type 2 diabetes who enrolled on the platform. One-year peer-reviewed, published health outcomes demonstrate the platform is effective for glycemic control, weight loss, and reducing hypoglycemic medications.
average weight loss
1.2% / 13mmol/mol
average HbA1c reduction
39% of patients
reduce their HbA1c under type 2 diagnosis threshold
40% of patients
on medication eliminate at least one of them
60% of patients
on insulin eliminate or reduce the medication
1 in 4 patients
put type 2 diabetes into remission
Read the paper: Saslow LR et al, JMIR Diabetes 2018;3(3):e12
At the one-year follow-up, participants who had completed the Low Carb Program achieved a significant average weight loss; the average weight loss from baseline to one year was 7.4kg, or 7% of body weight.
Mean body weight loss
Members who complete the Low Carb Program significantly reduce HbA1c by an average of 1.2% (13 mmol/mol).
(1.2%) HbA1c reduction
Members experienced significant reduction and elimination of medications from baseline to follow-up.
The bar chart below represents percentage of users who have reduced or eliminated at least one diabetes medication.
of patients eliminate or reduce diabetes medication
How does it compare to standard care at one year?
The Low Carb Program provides a sustainable approach to weight loss and blood glucose management.>
|Low Carb Program||Standard Care|
|HbA1c||⬇︎ 1.2%||⬆︎ 0.2%|
|Medication*||⬇︎ 54%||⬆︎ 9%|
|Remission||⬆︎ 26%||⬆︎ 0.1%|
* Diabetes medicines, excluding Metformin
Saslow LR, Summers C, Aikens JE, Unwin DJ Outcomes of a Digitally Delivered Low-Carbohydrate Type 2 Diabetes Self-Management Program: 1-Year Results of a Single-Arm Longitudinal Study, JMIR Diabetes. doi:10.2196/diabetes.9333
Hallberg et al. Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year. Diabetes Ther. Doi: 10.1007/s13300-018-0373-9
Advancing the evidence base
The Low Carb Program is innovating in both digital health and nutrition. As a result, the Low Carb Program is involved in a number of research studies with health and academic institutions across the globe.
Published outcomes demonstrate that the Low Carb Program is a scalable, effective and engaging solution for type 2 diabetes and prediabetes remission.
Low Carb Program: One Year Health Outcomes
The Low Carb Program’s one-year health outcomes followed 1,000 people and demonstrated an online program that teaches a carbohydrate-reduced diet to adults with type 2 diabetes can be effective for glycemic control, weight loss, and reducing hypoglycemic medications.
Sensitivity Analysis on Type 2 Diabetes Patients
Researchers at Medical School, University of Warwick conducted a sensitity analysis on patients involved in the Low Carb Program three-year study. No significant variance was found between age, gender, ethnicity or income.
Symphony Healthcare Services: Scaling Type 2 Remission
The Low Carb Program partnered with Symphony Healthcare Services in Wincanton, Somerset to achieve 50 cases of type 2 diabetes remission. At 3 months, there is a 97% platform enrolment, 86% completion and 8.1% body weight loss.
University of British Columbia: Usability study
The Low Carb Program has partnered with the Diabetes Prevention Research Group to evaluate the barriers and facilitators to engaging in the Low Carb Program and making dietary changes both within the time-period of the program and for a year follow-up.